Westerpark Vodka
QUALITY WINES OF SPAIN, F. L. NAVARRO LTD — BROOKLYN, NY
Netherlands
About Westerpark Vodka
Westerpark Vodka is a vodka produced in the Netherlands and classified as an 80-89 proof spirit. According to TTB records, the brand received its first label approval in 2020. The spirit is registered with a single distinct product offering within the vodka category. As a Netherlands-origin vodka in the 80-89 proof range, Westerpark Vodka represents a standard-proof expression within the broader vodka market. The brand maintains one approved label configuration on file with the Alcohol and Tobacco Tax and Trade Bureau. Details regarding production methods, ingredients, or specific characteristics beyond the proof range and origin designation are not available through TTB registration records. The 2020 approval date marks the initial documented entry of this brand into the TTB's Cola registry system.
| Label Name | Spirit Type | Status | Approval Date | Producer | |
|---|---|---|---|---|---|
 | Westerpark Vodka VODKA 80-89 PROOF FB | Vodka 80-89 Proof Fb | Approved | 2020-12-15 | QUALITY WINES OF SPAIN, F. L. NAVARRO LTD |
Page 1 of 1
Westerpark Vodka at a Glance
Westerpark Vodka has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof Fb. Labels approved between 2020-12-15 and 2020-12-15. Produced in Netherlands.
All information sourced from public TTB records.
Are you the owner or distributor of Westerpark Vodka?
Claim this brand listing to update information or get featured. Contact [email protected].
Produced At
Quality Wines Of Spain, F. L. Navarro LTDRelated Brands
- Van Gogh also from Netherlands
- Ketel One also from Netherlands
- Effen also from Netherlands
- Lumiere also from Netherlands
- Bols also from Netherlands
- Svedka also makes Vodka 80-89 Proof Fb
- Stoli also makes Vodka 80-89 Proof Fb
- Stolichnaya also makes Vodka 80-89 Proof Fb
- Beluga also makes Vodka 80-89 Proof Fb
- Mr Boston also makes Vodka 80-89 Proof Fb
Related Questions
Browse All Labels
Stay informed
Newsletter coming soon.
Follow us on X for new approvals, launches, and industry intelligence.